Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Why Is AVITA Medical (ASX:AVH) Hitting a 52-Week High Today?

AVITA Medical, Inc. develops and sells products for wound care and skin restoration, including the RECELL system and PermeaDerm, a biosynthetic wound matrix. It is listed on NASDAQ as RCEL and on the ASX as AVH.

Sonal Goyal | 21 October 2026

Identifai Genetics (ASX:ID1) at a 52-Week High: What’s Next for Investors?

Identifai Genetics Limited is developing Windrose, a prenatal screening platform that combines genomic sequencing, AI andMachine Learningto assess selected inherited conditions from a single maternal blood sample from about nine weeks of pregnancy. The technology originated at Tel Aviv University and is supported by …

Sonal Goyal | 21 October 2026

Holista Colltech (ASX:HCT) at a 52-Week Low: What’s Going On?

Holista Colltech Limited sells nutritional supplements and ingredients through its Supplements division and is developing agriculture products such as nano urea and a poultry probiotic.

Sonal Goyal | 21 October 2026

What’s Behind Saluda Medical’s (ASX:SLD) Slide to a 52-Week Low?

Saluda Medical, Inc. develops and sells the Evoke closed-loop spinal cord stimulation system for chronic pain, and operates in the United States, Europe and Australia.

Sonal Goyal | 21 October 2026

Alterity Therapeutics (ASX:ATH) Touches 52-Week Low Today: Key Reasons Explained

Alterity Therapeutics Limited is a clinical-stage biotechnology company listed on the ASX and, through American Depositary Shares under the symbol ATHE, on the Nasdaq Capital Market. It is developing ATH434, a candidate for multiple system atrophy (MSA), and operates a drug discovery platform targeting …

Sonal Goyal | 20 October 2026

Oneview Healthcare (ASX:ONE) Shares Sink to a 52-Week Low: What Investors Need to Know

Oneview Healthcare PLC develops and sells software for the healthcare sector. Its Oneview system was live on 15,092 endpoints at 30 June 2026, compared with 14,880 previously, and it reports in euros. The company is listed on the ASX under ARBN 610 611 768.

Sonal Goyal | 20 October 2026

Why Pharmx Technologies (ASX:PHX) Shares Are Falling Today

Pharmx Technologies Limited (ASX:PHX) is an ASX-listed company that reports on a financial year with first-quarter updates, and it releases business updates alongside analyst briefings. The announcement reviewed here does not describe its products, so its business is not detailed in this article beyond …

Sonal Goyal | 20 October 2026

What Does CSL’s (ASX:CSL) Latest Annual Report Mean for Investors?

CSL is a global biotechnology company with three main businesses: CSL Behring, which makes plasma-derived and recombinant therapies; CSL Seqirus, which makes influenza vaccines; and CSL Vifor, which focuses on iron deficiency and nephrology.

Sonal Goyal | 20 October 2026

Medibank (ASX:MPL): What the Latest Annual Report Says About Its Growth Prospects

Medibank is a private health insurer that says it serves about 6 million people. It operates the Medibank and ahm brands and a non-resident health insurance business, and its Medibank Health segment includes Amplar Health, which runs general practice and medical clinics and delivers …

Sonal Goyal | 20 October 2026

What Does Pro Medicus’s (ASX:PME) Latest Annual Report Mean for Investors?

Pro Medicus develops and sells the Visage medical imaging platform, which is used by radiologists and healthcare organisations, mainly in the United States. The company says its platform is used by about 11% of the US market, including 11 of the top 20 healthcare …

Sonal Goyal | 20 October 2026
Support

Hi! How can we help you today?

Loading…